Polysaccharide (PS) constitutes one of major classes of bio-macromolecules covering the surface of the bacterial pathogens, representing a major virulent determinant and immunogen. Several PS vaccines (including conjugated PS) have been developed to prevent the pathogen infections; these PS vaccines suffer from low yields, non-specific chemical conjugation, high costs, and delivery by injection. Recombinant attenuated Salmonella (RAS) are capable of delivering heterologous antigens, including PS, from a variety of pathogens, generating a range of immune responses including serum antibodies, mucosal IgA, and a panoply of cell-mediated immune responses at local and distal sites. These RAS are designed and constructed to deliver protein or DNA antigens. In this work, we undertake the construction of attenuated Salmonella strains designed specifically for delivery of bacterial PS antigens, including O-antigen polysaccharides (O-PS) from Gram-negative pathogens and capsular polysaccharides (C-PS) from Gram-positive pathogens. In our strains, these complex carbohydrates will be covalently linked to the Salmonella cell surface. Using our novel regulated delayed gene expression technology, all native Salmonella surface carbohydrates will be present at the time of immunization to facilitate Salmonella-host interactions necessary for optimal immunogenicity, but will be down-regulated in vivo, after colonization of host lymphatic tissues. Conversely, synthesis of heterologous carbohydrates will not occur until after the vaccine strain has colonized host tissues. Down-regulation of Salmonella carbohydrates will permit optimal expression and presentation of heterologous carbohydrates without interference or steric blocking by Salmonella surface structures. Linking the target polysaccharide antigens to the Salmonella cell surface provides the strong adjuvant effects of Salmonella LPS. In addition, these biologically conjugated polysaccharide vaccines will allow us to take advantage of the known ability of traditional, chemically conjugated polysaccharide antigens to stimulate both T-cell dependent and T-cell independent immune responses to the target antigen.

Public Health Relevance

Orally administered recombinant attenuated Salmonella (RAS) can deliver antigens from a variety of different pathogens, generating a range of immune responses. However, current RAS were designed to facilitate delivery of protein antigens and/or DNA vaccines. The goal of this project is to construct innovative RAS to synthesize and deliver heterologous polysaccharides derived from both Gram-negative and Gram-positive bacteria to induce robust protective immune responses providing protection against a variety of mucosal bacterial pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI112680-02
Application #
9171967
Study Section
Vaccines Against Microbial Diseases (VMD)
Program Officer
Alexander, William A
Project Start
2015-08-01
Project End
2020-01-31
Budget Start
2016-03-03
Budget End
2017-01-31
Support Year
2
Fiscal Year
2016
Total Cost
$343,751
Indirect Cost
$114,584
Name
University of Florida
Department
Pathology
Type
Schools of Veterinary Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Li, Pei; Liu, Qing; Luo, Hongyan et al. (2018) Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens. NPJ Vaccines 3:1
Han, Yue; Liu, Qing; Yi, Jie et al. (2017) A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection. Pathog Dis 75:
Li, Pei; Liu, Qing; Luo, Hongyan et al. (2017) O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections. Front Immunol 8:1647
Hu, Bo; Lara-Tejero, Maria; Kong, Qingke et al. (2017) In Situ Molecular Architecture of the Salmonella Type III Secretion Machine. Cell 168:1065-1074.e10
Liu, Qiong; Liu, Qing; Yi, Jie et al. (2016) Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model. Int J Med Microbiol 306:697-706
Liu, Qiong; Liu, Qing; Yi, Jie et al. (2016) Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge. Sci Rep 6:34776
Huang, Chun; Liu, Qing; Luo, Yali et al. (2016) Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge. Vaccine 34:4285-92